The advantages of nebulizing drug delivery method is more effective, quick, safe and convenient for respiratory diseases.
More than 100 million people in China suffer from chronic obstructive pulmonary disease (COPD), and respiratory related diseases, including asthma, pneumonia, pulmonary fibrosis and RSV infection, have become the third leading cause of death in China after cardiovascular and cerebrovascular diseases and malignant tumors. Although the current drugs on the market have not fully met the clinical treatment needs, it is generally believed that aerosol inhalation therapy is an effective therapy for respiratory diseases.
The large absorption surface area, rich capillary network, and thin alveolar epithelial cell layer make pulmonary administration quick and effective.
The first pass effect of the liver can be avoided. The activity of biological enzymes is low, which reduces the hydrolysis of drugs, making it easy for the drugs to be quickly absorbed through the alveolar surface and maintaining their biological activity, allowing them to exert an efficient therapeutic effect in the local lungs.
Local administration, low dose, small toxic and side effects, and few systemic adverse reactions.
It does not require the patient's deliberate cooperation, is less irritating when administered, has good compliance, and is suitable for acute and long-term treatment.
"Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration."
Dec 18, 2024
The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]
Dec 12, 2024
Neurodegenerative diseases leading to Parkinson's disease (PD) and Alzheimer's disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]
Dec 05, 2024
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg CBD per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by […]
Nov 26, 2024
Ultrasonic atomization uses ultrasonic directional pressure to make the liquid surface bulge, and cavitation occurs around the bulging liquid surface, causing the liquid to be atomized into small molecular mist. The oscillation frequency of the ultrasonic atomizer is 1.7MHz or 2.4MHz, which exceeds the human hearing range. The electronic oscillation is harmless to humans and […]
Nov 21, 2024